KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $102.7 million.

  • Bio-Rad Laboratories' Other Non-Current Assets rose 78.51% to $102.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $102.7 million, marking a year-over-year increase of 78.51%. This contributed to the annual value of $102.7 million for FY2025, which is 78.51% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Other Non-Current Assets of $102.7 million as of Q4 2025, which was up 78.51% from $109.0 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Rad Laboratories' Other Non-Current Assets peaked at $109.0 million during Q3 2025, and registered a low of $92.2 million during Q1 2021.
  • For the 5-year period, Bio-Rad Laboratories' Other Non-Current Assets averaged around $100.6 million, with its median value being $101.3 million (2022).
  • In the last 5 years, Bio-Rad Laboratories' Other Non-Current Assets skyrocketed by 2948.36% in 2021 and then tumbled by 921.4% in 2022.
  • Over the past 5 years, Bio-Rad Laboratories' Other Non-Current Assets (Quarter) stood at $104.2 million in 2021, then dropped by 9.21% to $94.6 million in 2022, then increased by 0.32% to $94.9 million in 2023, then grew by 7.38% to $101.9 million in 2024, then grew by 0.79% to $102.7 million in 2025.
  • Its Other Non-Current Assets was $102.7 million in Q4 2025, compared to $109.0 million in Q3 2025 and $107.9 million in Q2 2025.